KDR and glioma: VEGF and high-affinity VEGF receptor Flk1/KDR (VEGFR2) are key regulators of glioma angiogenesis, thus, inhibition of VEGFR2 expression would inhibit the development of new blood vessels within the tumor microenvironment (TME) and inhibit glioma progression.